
IRadimed Stock: Reduce Equity Beta With ~27% Upside Capture (NASDAQ:IRMD)
simonkr/E+ via Getty Images Investment Summary The June selloff has opened the floodgates for value opportunities within the medical technology (“medtech”) universe. Healthcare/medtech as an equity factor has traditionally provided a defensive overlay to equity […]